Measuring success: The challenge of social protection in helping eliminate tuberculosis

English version České info

In this Perspective on the research article by William Rudgard and colleagues, Priya Shete and coauthor discuss the challenges of measuring the impact of social protection programs such as cash transfers.

Vyšlo v časopise: Measuring success: The challenge of social protection in helping eliminate tuberculosis. PLoS Med 14(11): e32767. doi:10.1371/journal.pmed.1002419
Kategorie: Perspective
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1002419

Souhrn

Zdroje

1. Lonnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med. 2009;68(12):2240–6. doi: 10.1016/j.socscimed.2009.03.041 19394122.

2. Tanimura T, Jaramillo E, Weil D, Raviglione M, Lonnroth K. Financial burden for tuberculosis patients in low -⁠ and middle-income countries: a systematic review. Eur Respir J. 2014;43(6):1763–75. doi: 10.1183/09031936.00193413 24525439; PubMed Central PMCID: PMC4040181.

3. Mauch V, Bonsu F, Gyapong M, Awini E, Suarez P, Marcelino B, et al. Free tuberculosis diagnosis and treatment are not enough: patient cost evidence from three continents. Int J Tuberc Lung Dis. 2013;17(3):381–7. doi: 10.5588/ijtld.12.0368 23407227.

4. Richter LM, Lonnroth K, Desmond C, Jackson R, Jaramillo E, Weil D. Economic support to patients in HIV and TB grants in rounds 7 and 10 from the global fund to fight AIDS, tuberculosis and malaria. PLoS ONE. 2014;9(1):e86225. doi: 10.1371/journal.pone.0086225 24489702; PubMed Central PMCID: PMC3904874.

5. Sripad A, Castedo J, Danford N, Zaha R, Freile C. Effects of Ecuador's national monetary incentive program on adherence to treatment for drug-resistant tuberculosis. Int J Tuberc Lung Dis. 2014;18(1):44–8. doi: 10.5588/ijtld.13.0253 24365551.

6. Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, et al. WHO's new end TB strategy. Lancet. 2015;385(9979):1799–801. doi: 10.1016/S0140-6736(15)60570-0 25814376.

7. Devereux S, Sabates-Wheeler R. Transformative Social Protection. Working Paper No. 232. Institute for Development Studies; Brighton: University of Sussex; 2004.

8. Rudgard WE, Evans CA, Sweeney S, Wingfield T, Lonnroth K, Barreira D, et al. Eliminating Catastrophic TB-Related Costs in Low -⁠ and Middle-Income Countries: The Potential Role of Cash Transfer Programmes. PLoS Med. 2017; 14(11): e1002418.

9. O’Donnell O, van Doorslaer E, Wagstaff A, Lindelow M. Catastrophic Payments for Health Care. 2008. In: Analyzing Health Equity Using Household Survey Data [Internet]. Washington D.C.: The World Bank Group; [203–12]. [cited 2017 Aug 14]. Available from: www.worldbank.org/analyzinghealthequity.

10. Wingfield T, Boccia D, Tovar M, Gavino A, Zevallos K, Montoya R, et al. Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru. PLoS Med. 2014;11(7):e1001675. doi: 10.1371/journal.pmed.1001675 25025331; PubMed Central PMCID: PMC4098993.

11. Siroka A, Ponce NA, Lonnroth K. Association between spending on social protection and tuberculosis burden: a global analysis. Lancet Infect Dis. 2016;16(4):473–9. Epub 2016/01/05. doi: 10.1016/S1473-3099(15)00401-6 26725446; PubMed Central PMCID: PMC4834192.

12. Wingfield T, Tovar MA, Huff D, Boccia D, Montoya R, Ramos E, et al. The economic effects of supporting tuberculosis-affected households in Peru. Eur Respir J. 2016. doi: 10.1183/13993003.00066–2016 27660507.

13. Wingfield T, Tovar MA, Huff D, Boccia D, Montoya R, Ramos E, et al. A randomized controlled study of socioeconomic support to enhance tuberculosis prevention and treatment, Peru. Bull World Health Organ. 2017;95(4):270–80. Epub 2017/05/10. doi: 10.2471/BLT.16.170167 28479622; PubMed Central PMCID: PMC5407248.

14. World Health Organization Protocol for survey to determine direct and indirect costs due to TB and to estimate proportion of TB-affected households experiencing catastrophic total costs due to TB. Field testing version. Geneva2015. [cited 2017 Aug 15]. Available from: http://www.who.int/tb/advisory_bodies/impact_measurement_taskforce/meetings/tf6_background_5a_patient_cost_surveys_protocol.pdf?ua=1.

15. World Health Organization. The World Health Report 2013: Research for Universal Health Coverage. Luxembourg: 2013.